Glycoprotein B (EBV)

Glycoprotein B (EBV) Molekülinformation

Englischer Name	Envelope glycoprotein B, gB	Anzahl der inverkehr gebrachten Arzneimittel	0
Anzahl der klinischen Arzneimittel	2	Target-Alias	UL55
Höchste Forschungs- und Entwicklungsphase	Phase 2 Clinical

Englischer Name	Envelope glycoprotein B, gB
Target-Alias	UL55
Anzahl der inverkehr gebrachten Arzneimittel	0
Anzahl der klinischen Arzneimittel	2
Höchste Forschungs- und Entwicklungsphase	Phase 2 Clinical

Produktanfrage

Glycoprotein B (EBV) Molekülhintergrund

Epstein-Bar Virus (EBV), also known as human herpesvirus 4, belongs to gamma herpes virus family and is a very common human virus worldwide. EBV causes infectious mononucleosis (IM) and also associates to some specific types of cancers such as Burkitt’s lymphoma (BL) and gastric carcinoma (GC). Glycoprotein B (gB) plays an important role in viral entry by binding with αvβ6/αvβ8 integrins to trigger the membrane fusion and entry process of epithelial cells, which makes it become an great target for EBV research.

Glycoprotein B (EBV) Molekülalias

Klinische Arzneimittelinformation

Englischer Name	Forschungscode	Forschungsphase	Firma	Indikationen	Klinische Studie
Fiztasovimab	NPC-21	Phase 2 Clinical	Nobelpharma Co Ltd	Cytomegalovirus Infections	Details
TRL-345	CMV-345; TRL-345	Phase 1 Clinical	Trellis Bioscience LLC	Cytomegalovirus Infections	Details